Celligenics Unveils Corporate Video Titled Enabling Cellular Therapeutics (May 2021)
Celligenics is pleased to unveil its first corporate video, titled Enabling Cellular Therapeutics. The video introduces our research team and showcases our research facility, reiterating our endeavour to achieve our vision and mission in providing accessible and affordable healthcare solutions for everyone.
Recent Posts
Mar 21, 2023
Celligenics Announces China Market Entry, & Signs MOU With West China Hospital
Celligenics is pleased to announce that we have signed a memorandum of understanding with West China Hospital (Hua Xi) of Sichuan University at the 22nd Singapore-Sichuan Trade and Investment Committee Meeting.
Mar 21, 2023
Celligenics Announces China Market Entry, & Signs MOU With West China Hospital
Celligenics is pleased to announce that we have signed a memorandum of understanding with West China Hospital (Hua Xi) of Sichuan University at the 22nd Singapore-Sichuan Trade and Investment Committee Meeting.
Mar 21, 2023
Celligenics Announces China Market Entry, & Signs MOU With West China Hospital
Celligenics is pleased to announce that we have signed a memorandum of understanding with West China Hospital (Hua Xi) of Sichuan University at the 22nd Singapore-Sichuan Trade and Investment Committee Meeting.
Mar 21, 2023
Celligenics, NTU, & SRIS Collaborate On New Therapy For Chronic Wounds (Sep 2021)
Celligenics is pleased to announce that we have signed a research collaboration agreement with local research institutes, Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chien School of Medicine (LKCMedicine) and the Skin Research Institute of Singapore (SRIS), under the Skin Innovation Grant (SIG).
Mar 21, 2023
Celligenics, NTU, & SRIS Collaborate On New Therapy For Chronic Wounds (Sep 2021)
Celligenics is pleased to announce that we have signed a research collaboration agreement with local research institutes, Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chien School of Medicine (LKCMedicine) and the Skin Research Institute of Singapore (SRIS), under the Skin Innovation Grant (SIG).
Mar 21, 2023
Celligenics, NTU, & SRIS Collaborate On New Therapy For Chronic Wounds (Sep 2021)
Celligenics is pleased to announce that we have signed a research collaboration agreement with local research institutes, Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chien School of Medicine (LKCMedicine) and the Skin Research Institute of Singapore (SRIS), under the Skin Innovation Grant (SIG).
Mar 21, 2023
Celligenics Signs MOU With Series A Investor Best World International (April 2021)
Celligenics is pleased to announce that we have signed a Memorandum of Understanding (MOU) with our Series A investor, Best World International (BWI)
Mar 21, 2023
Celligenics Signs MOU With Series A Investor Best World International (April 2021)
Celligenics is pleased to announce that we have signed a Memorandum of Understanding (MOU) with our Series A investor, Best World International (BWI)
Mar 21, 2023
Celligenics Signs MOU With Series A Investor Best World International (April 2021)
Celligenics is pleased to announce that we have signed a Memorandum of Understanding (MOU) with our Series A investor, Best World International (BWI)
GET IN TOUCH
Partner With Celligenics
We welcome partnerships to explore new opportunities together at the frontier of regenerative science, across global markets.
Or email us at info@celligenics.com
GET IN TOUCH
Partner With Celligenics
We welcome partnerships to explore new opportunities together at the frontier of regenerative science, across global markets.
Or email us at info@celligenics.com
GET IN TOUCH
Partner With Celligenics
We welcome partnerships to explore new opportunities together at the frontier of regenerative science, across global markets.
Or email us at info@celligenics.com